標(biāo)題: Titlebook: Management of Early Progressive Corneal Ectasia; Accelerated Crosslin Cosimo Mazzotta,Frederik Raiskup,Claudio Traversi Book 2017 Springer [打印本頁] 作者: CYNIC 時(shí)間: 2025-3-21 19:06
書目名稱Management of Early Progressive Corneal Ectasia影響因子(影響力)
書目名稱Management of Early Progressive Corneal Ectasia影響因子(影響力)學(xué)科排名
書目名稱Management of Early Progressive Corneal Ectasia網(wǎng)絡(luò)公開度
書目名稱Management of Early Progressive Corneal Ectasia網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Management of Early Progressive Corneal Ectasia被引頻次
書目名稱Management of Early Progressive Corneal Ectasia被引頻次學(xué)科排名
書目名稱Management of Early Progressive Corneal Ectasia年度引用
書目名稱Management of Early Progressive Corneal Ectasia年度引用學(xué)科排名
書目名稱Management of Early Progressive Corneal Ectasia讀者反饋
書目名稱Management of Early Progressive Corneal Ectasia讀者反饋學(xué)科排名
作者: ADORE 時(shí)間: 2025-3-21 22:11 作者: 環(huán)形 時(shí)間: 2025-3-22 01:09 作者: Processes 時(shí)間: 2025-3-22 06:39
Refractive Crosslinking: ACXL Plus, a reduction in corneal thickness, a variation in posterior and anterior corneal curvature, fluctuation and loss of visual acuity attributable to irregular astigmatism with or without a reduction in corneal transparency.作者: Filibuster 時(shí)間: 2025-3-22 10:13 作者: Abbreviate 時(shí)間: 2025-3-22 16:15 作者: Intercept 時(shí)間: 2025-3-22 20:23
Crosslinking Results and Literature Overview,Corneal crosslinking (CXL) is performed in an outpatient setting. Thirty minutes in advance, a systemic analgosedation can be administered. Some surgeons use Pilocarpin 2% eye drops in order to reduce potential thermal and photochemical effects of UVA-radiation on the retina and the lens.作者: Terrace 時(shí)間: 2025-3-22 21:19 作者: 微枝末節(jié) 時(shí)間: 2025-3-23 03:12
Accelerated Crosslinking Protocols,and published by Wollensak et al. in 2003 also in Dresden [1, 2]. A standardized protocol that we refer to as a “Dresden protocol” involves abrasion of the corneal epithelium, followed by riboflavin application for 30 min as a photosensitizer and subsequent UVA illumination of 3 mW/cm. of its intens作者: 規(guī)范要多 時(shí)間: 2025-3-23 06:27 作者: Merited 時(shí)間: 2025-3-23 13:47 作者: Innocence 時(shí)間: 2025-3-23 17:00
Keratoconus Classification, ACXL Indications and Therapy Flowchart, <2 mm from the pupil center or peripheral >2 mm), curvatures, thickness, high-order aberrations, documented clinical (UCVA, BSCVA) and instrumental (topographic, pachymetric and/or aberrometric) progression [1]. Therapeutic approach must be also strongly connected to patient’s age according to diff作者: cloture 時(shí)間: 2025-3-23 20:38
Cosimo Mazzotta,Frederik Raiskup,Stefano Baiocchi,Giuliano Scarcelli,Marc D. Friedman,Claudio Traver作者: 有毛就脫毛 時(shí)間: 2025-3-24 02:15
Cosimo Mazzotta,Frederik Raiskup,Stefano Baiocchi,Giuliano Scarcelli,Marc D. Friedman,Claudio Traver作者: expository 時(shí)間: 2025-3-24 05:00
Cosimo Mazzotta,Frederik Raiskup,Stefano Baiocchi,Giuliano Scarcelli,Marc D. Friedman,Claudio Traver作者: Acetaminophen 時(shí)間: 2025-3-24 07:03
Cosimo Mazzotta,Frederik Raiskup,Stefano Baiocchi,Giuliano Scarcelli,Marc D. Friedman,Claudio Traver作者: 使乳化 時(shí)間: 2025-3-24 10:45
Cosimo Mazzotta,Frederik Raiskup,Stefano Baiocchi,Giuliano Scarcelli,Marc D. Friedman,Claudio Traver作者: Foment 時(shí)間: 2025-3-24 15:45 作者: goodwill 時(shí)間: 2025-3-24 19:26 作者: hematuria 時(shí)間: 2025-3-24 23:48 作者: 富足女人 時(shí)間: 2025-3-25 03:30 作者: 有特色 時(shí)間: 2025-3-25 10:04 作者: Inflamed 時(shí)間: 2025-3-25 15:21 作者: persistence 時(shí)間: 2025-3-25 16:12
ACXL Beyond Keratoconus: Post-LASIK Ectasia, Post-RK Ectasia and Pellucid Marginal Degeneration,ymmetric inferior corneal steeping. Over time, there can be associated thinning of the central and paracentral ectatic corneal tissue. Normally this it come to patient’s clinical attention when there is associated loss of uncorrect distance visual acuity (UDVC) [1, 2].作者: 整理 時(shí)間: 2025-3-25 22:54 作者: 高度表 時(shí)間: 2025-3-26 00:45 作者: 事先無準(zhǔn)備 時(shí)間: 2025-3-26 05:28
at the forefront of cross-linking treatment research.Brings .This book provides a rapid overview of crosslinking protocols and the therapeutic guidelines to optimize the application according to patients age and ectasia staging. This book is unique in the field of crosslinking therapy, as it gives t作者: inhumane 時(shí)間: 2025-3-26 10:26
7樓作者: 牲畜欄 時(shí)間: 2025-3-26 15:35
7樓作者: 殺菌劑 時(shí)間: 2025-3-26 20:26
8樓作者: Intuitive 時(shí)間: 2025-3-26 21:07
8樓作者: CLOUT 時(shí)間: 2025-3-27 05:12
8樓作者: 農(nóng)學(xué) 時(shí)間: 2025-3-27 07:23
8樓作者: BROW 時(shí)間: 2025-3-27 11:32
9樓作者: 閑蕩 時(shí)間: 2025-3-27 17:37
9樓作者: PHON 時(shí)間: 2025-3-27 18:21
9樓作者: 消耗 時(shí)間: 2025-3-27 21:55
9樓作者: 尾巴 時(shí)間: 2025-3-28 04:48
10樓作者: 保守黨 時(shí)間: 2025-3-28 08:24
10樓作者: 刺激 時(shí)間: 2025-3-28 13:36
10樓作者: Gratulate 時(shí)間: 2025-3-28 18:39
10樓
